Related references
Note: Only part of the references are listed.Intracellular pathways underlying the effects of lithium
Livia Pasquali et al.
BEHAVIOURAL PHARMACOLOGY (2010)
Wnt/β-Catenin Signaling Activates and Determines Hepatic Zonal Expression of Glutathione S-Transferases in Mouse Liver
Stefanie Giera et al.
TOXICOLOGICAL SCIENCES (2010)
Inducibility of Drug-Metabolizing Enzymes by Xenobiotics in Mice with Liver-Specific Knockout of Ctnnb1
Albert Braeuning et al.
DRUG METABOLISM AND DISPOSITION (2009)
The Glycogen Synthase Kinase Inhibitor 3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763) Is a Partial Agonist of the Aryl Hydrocarbon Receptor
Albert Braeuning et al.
DRUG METABOLISM AND DISPOSITION (2009)
Convergence of Wnt Signaling on the HNF4α-Driven Transcription in Controlling Liver Zonation
Marta Colletti et al.
GASTROENTEROLOGY (2009)
Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in Apc>Min/+ mice with natural ligands
Kaname Kawajiri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Liver-specific loss of β-catenin results in delayed hepatocyte proliferation after partial hepatectomy
Shigeki Sekine et al.
HEPATOLOGY (2007)
Conditional deletion of β-catenin reveals its role in liver growth and regeneration
Xinping Tan et al.
GASTROENTEROLOGY (2006)
Regulation of CYP1A1 gene expression by the antioxidant tert-butylhydroquinone
Thomas D. Schreiber et al.
DRUG METABOLISM AND DISPOSITION (2006)
Apc tumor suppressor gene is the zonation-keeper of mouse liver
Samira Benhamouche et al.
DEVELOPMENTAL CELL (2006)
Liver-specific loss of β-catenin blocks glutamine synthesis pathway activity and cytochrome P450 expression in mice
S Sekine et al.
HEPATOLOGY (2006)
Zonal gene expression in murine liver: Lessons from tumors
S Hailfinger et al.
HEPATOLOGY (2006)
Interaction of nuclear receptors with the Wnt/β-catenin/Tcf signaling axis:: Wnt you like to know?
DJ Mulholland et al.
ENDOCRINE REVIEWS (2005)
Genotype-phenotype relationships in hepatocellular tumors from mice and man
S Stahl et al.
HEPATOLOGY (2005)
Induction of phase I, II and III drug metabolism/transport by xenobiotics
CJ Xu et al.
ARCHIVES OF PHARMACAL RESEARCH (2005)
Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor
O Hankinson
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2005)
Identification of aryl hydrocarbon receptor as a putative Wnt/β-catenin pathway target gene in prostate cancer cells
DR Chesire et al.
CANCER RESEARCH (2004)
Liver-enriched transcription factors in liver function and development. Part II: the C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation
H Schrem et al.
PHARMACOLOGICAL REVIEWS (2004)
The Wnt connection to tumorigenesis
J Behrens et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2004)
Contribution of the Ah receptor to the phenolic antioxidant-mediated expression of human and rat UDP-glucuronosyltransferase UGT1A6 in Caco-2 and rat hepatoma 5L cells
PA Münzel et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Modulation of oestrogen receptor signalling by association with the activated dioxin receptor
F Ohtake et al.
NATURE (2003)